Kim Lauper
@kimlauper.bsky.social
Rheumatologist
Research interests: RA, crystal arthritis 💎, vaccines 💉, registry studies, methodology
Consultant, Div. of Rheumatology, Geneva University Hospitals 🇨🇭
MD & Lecturer, University of Geneva 🇨🇭
PhD in Epidemiology, University of Manchester 🇬🇧
Research interests: RA, crystal arthritis 💎, vaccines 💉, registry studies, methodology
Consultant, Div. of Rheumatology, Geneva University Hospitals 🇨🇭
MD & Lecturer, University of Geneva 🇨🇭
PhD in Epidemiology, University of Manchester 🇬🇧
March 28, 2025 at 5:29 PM
📄 Full paper in RMD open : doi.org/10.1136/rmdo...
💾 Open access data and code: gitlab.unige.ch/trial_integr...
#GenderEquity #RCT #AcademicResearch #Rheumatology
💾 Open access data and code: gitlab.unige.ch/trial_integr...
#GenderEquity #RCT #AcademicResearch #Rheumatology
Trends and influences in women authorship in randomised controlled trials in rheumatology: a comprehensive analysis of all published RCTs from 2009 to 2023
Objectives We examined the evolution and influencing factors of women’s authorship in randomised controlled trials (RCTs) published in rheumatology.
Methods We analysed all RCTs published in rheumato...
rmdopen.bmj.com
March 28, 2025 at 10:19 AM
📄 Full paper in RMD open : doi.org/10.1136/rmdo...
💾 Open access data and code: gitlab.unige.ch/trial_integr...
#GenderEquity #RCT #AcademicResearch #Rheumatology
💾 Open access data and code: gitlab.unige.ch/trial_integr...
#GenderEquity #RCT #AcademicResearch #Rheumatology
Women were less involved in industry-funded or large-sample RCTs (often high-impact), and more often employed in pharma (non-academic roles).
But: when the last author was a woman, the first author was more likely to be a woman too.
But: when the last author was a woman, the first author was more likely to be a woman too.
March 28, 2025 at 10:19 AM
Women were less involved in industry-funded or large-sample RCTs (often high-impact), and more often employed in pharma (non-academic roles).
But: when the last author was a woman, the first author was more likely to be a woman too.
But: when the last author was a woman, the first author was more likely to be a woman too.
What we found:
Women = 40% of all authors
Only 37% of first authors and 26% of last authors are women
No improvement over time
Women = 40% of all authors
Only 37% of first authors and 26% of last authors are women
No improvement over time
March 28, 2025 at 10:19 AM
What we found:
Women = 40% of all authors
Only 37% of first authors and 26% of last authors are women
No improvement over time
Women = 40% of all authors
Only 37% of first authors and 26% of last authors are women
No improvement over time
Using the database from his and Michel Iudici's SNSF-funded project on transparency in RCTs (data.snf.ch/grants/grant...), we analysed ALL rheumatology RCTs published from 2009 to 2023.
That’s over 1,000 trials and nearly 11,000 authors.
That’s over 1,000 trials and nearly 11,000 authors.
SNSF Data Portal
The Swiss National Science Foundation's Data Portal presents interactive Key Figures, facts on funded projects and involved people in the Grant Search and the COVID-19 project registry, Dataset downlo...
data.snf.ch
March 28, 2025 at 10:19 AM
Using the database from his and Michel Iudici's SNSF-funded project on transparency in RCTs (data.snf.ch/grants/grant...), we analysed ALL rheumatology RCTs published from 2009 to 2023.
That’s over 1,000 trials and nearly 11,000 authors.
That’s over 1,000 trials and nearly 11,000 authors.
And a funny round rainbow a bit above! 🌈
December 2, 2024 at 6:48 PM
And a funny round rainbow a bit above! 🌈
Hi, can you add me?
November 23, 2024 at 4:55 AM
Hi, can you add me?